4.8 Article

Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 6, Pages 2966-2977

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI133753

Keywords

-

Funding

  1. Tobacco-Related Disease Research Program [28DT-008]
  2. UCSF Discovery Fellows Program
  3. Achievement Rewards for College Scientists Scholarship
  4. NIH [HL127240, T32GM008568]
  5. American Heart Association [17PRE33670181]
  6. Gladstone Institutes
  7. Younger Family Fund
  8. NIH/National Center for Research Resources grant [C06 RR018928]

Ask authors/readers for more resources

Salt-inducible kinases (SIKs) are key regulators of cellular metabolism and growth, but their role in cardiomyocyte plasticity and heart failure pathogenesis remains unknown. Here, we showed that loss of SIK1 kinase activity protected against adverse cardiac remodeling and heart failure pathogenesis in rodent models and cardiomyocytes derived from human induced pluripotent stem cells. We found that SIK1 phosphorylated and stabilized histone deacetylase 7 (HDAC7) protein during cardiac stress, an event that is required for pathologic cardiomyocyte remodeling. Gain- and loss-of-function studies of HDAC7 in cultured cardiomyocytes implicated HDAC7 as a prohypertrophic signaling effector that can induce c-Myc expression, indicating a functional departure from the canonical MEF2 corepressor function of class Ila HDACs. Taken together, our findings reveal what we believe to be a previously unrecognized role for a SIK1/HDAC7 axis in regulating cardiac stress responses and implicate this pathway as a potential target in human heart failure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available